High Throughput Production of mRNA

High Throughput Production of mRNA

High Throughput Production of mRNA
We hope that you enjoyed hearing from industry leaders about how they are working to expedite therapy development, incorporate digital therapeutics at scale, and improve patient outcomes. For more information on other ways AWS can help your healthcare and life sciences organization, visit us at: https://amzn.to/2NP30RW or contact the team at: [email protected]

Moderna Therapeutics (NASDAQ: MRNA) is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a broad spectrum of diseases. Moderna’s platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing the Company the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immunooncology, rare diseases and cardiovascular diseases, independently and with strategic collaborators.

View on YouTube

Sharing is caring!

Comments are closed.